PIOGLITAZONE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
43547-428 -
Package NDC
43547-428-03 -
Package NDC
43547-428-09 -
Package NDC
43547-428-50 -
Application number
ANDA207806 -
SPL ID
258c9ca5-41a1-44dc-8d3a-958bf6613e40 -
SPL set ID
1b77dbeb-61d1-4df3-872b-2f4f75a110db -
UNII
X4OV71U42S -
RxCUI
312440 -
RxCUI
312441 -
RxCUI
317573
What the source publishes
- Labeler
- Solco Healthcare LLC
- Active ingredients
- Pioglitazone
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "PIOGLITAZONE",
"splId": "258c9ca5-41a1-44dc-8d3a-958bf6613e40",
"labels": [
{
"setId": "1b77dbeb-61d1-4df3-872b-2f4f75a110db",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1b77dbeb-61d1-4df3-872b-2f4f75a110db",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1b77dbeb-61d1-4df3-872b-2f4f75a110db"
}
],
"routes": [
"ORAL"
],
"labeler": "Solco Healthcare LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (43547-428-03)",
"package_ndc": "43547-428-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20180520"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (43547-428-09)",
"package_ndc": "43547-428-09",
"identifierStatus": "well-formed",
"marketing_start_date": "20180520"
},
{
"sample": false,
"description": "500 TABLET in 1 BOTTLE (43547-428-50)",
"package_ndc": "43547-428-50",
"identifierStatus": "well-formed",
"marketing_start_date": "20180520"
}
],
"productId": "43547-428_258c9ca5-41a1-44dc-8d3a-958bf6613e40",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "43547-428",
"deaSchedule": null,
"genericName": "Pioglitazone",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "PIOGLITAZONE",
"strength": "45 mg/1"
}
],
"applicationNumber": "ANDA207806",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20180520",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175596",
"N0000175375",
"N0000180186",
"N0000175377",
"N0000180190",
"M0447306"
],
"upc": [
"0343547428099",
"0343547426095"
],
"unii": [
"X4OV71U42S"
],
"rxcui": [
"312440",
"312441",
"317573"
],
"spl_set_id": [
"1b77dbeb-61d1-4df3-872b-2f4f75a110db"
],
"pharm_class_cs": [
"Thiazolidinediones [CS]"
],
"pharm_class_epc": [
"Peroxisome Proliferator Receptor alpha Agonist [EPC]",
"Peroxisome Proliferator Receptor gamma Agonist [EPC]",
"Thiazolidinedione [EPC]"
],
"pharm_class_moa": [
"Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]",
"Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]"
],
"manufacturer_name": [
"Solco Healthcare LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:43547-428_258c9ca5-41a1-44dc-8d3a-958bf6613e40"